# Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

> **NCT03274687** · PHASE3 · COMPLETED · sponsor: **NRG Oncology** · enrollment: 296 (actual)

## Conditions studied

- Prostate Adenocarcinoma
- Stage I Prostate Adenocarcinoma AJCC v7
- Stage II Prostate Adenocarcinoma AJCC v7
- Stage III Prostate Adenocarcinoma AJCC v7

## Interventions

- **RADIATION:** Hypofractionated Radiation Therapy
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Quality-of-Life Assessment
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT03274687
- **Lead sponsor:** NRG Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-28
- **Primary completion:** 2021-02-22
- **Final completion:** 2025-12-23
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03274687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03274687, "Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03274687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*